When agency enforcement of the Robinson-Patman Act (RPA) was revived near the end of the Biden administration, it was met with mixed reactions. Given the Republican Commissioners’ disapproval of the complaints, it came as no...more
Each May, the American Health Law Association holds its Health Care Transactions Conference in Nashville, Tennessee. In addition to panels covering a wide variety of non-antitrust transactions issues (Stark Law, anyone?), we...more
In the days leading up to President Trump’s inauguration, the Biden FTC rushed to initiate major lawsuits and to tie a bow on various antitrust policy efforts. In a series of dissenting statements, the minority Republican...more
1/27/2025
/ Anti-Competitive ,
Antitrust Division ,
Antitrust Litigation ,
Antitrust Provisions ,
Biden Administration ,
Competition ,
Enforcement Actions ,
Exxon Mobil ,
Federal Trade Commission (FTC) ,
Gun-Jumping ,
Healthcare ,
Human Resources Professionals ,
John Deere ,
Merger Controls ,
Mergers ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Popular ,
Portfolio Companies ,
Private Equity ,
Right to Repair ,
Robinson-Patman Act ,
Section 7 ,
Settlement ,
Trump Administration